Zimmer Biomet Holdings (NYSE:ZBH): According to 14 Analysts, The short term target price has been estimated at $ 128.57.The target price could deviate by a maximum of $8.97 from the forecast price. In the near term, the target price could hit a high of $135 and a low of $ 105.
Many analysts have stated their opinion on the company shares. Guggenheim Securities initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH). The rating major has initiated the coverage with neutral rating on the shares. The rating by the firm was issued on June 9, 2016. For the current week, the company shares have a recommendation consensus of Buy.
On the companys insider trading activities, The Securities and Exchange Commission has divulged that Williamson Daniel E., officer (Group President) of Zimmer Biomet Holdings, Inc., had unloaded 10,000 shares at an average price of $119.77 in a transaction dated on June 9, 2016. The total value of the transaction was worth $1,197,700.
Zimmer Biomet Holdings (NYSE:ZBH) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.99 points or 0.83% at $118.24 with 1,578,051 shares getting traded. Post opening the session at $118.47, the shares hit an intraday low of $118.17 and an intraday high of $119.96 and the price was in this range throughout the day. The company has a market cap of $23,558 million and the number of outstanding shares have been calculated to be 199,238,890 shares. The 52-week high of Zimmer Biomet Holdings (NYSE:ZBH) is $123.43 and the 52-week low is $88.27.
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.